Just looked at the report. Seems like folks are over-reacting, not seeing the benefit of the product. I don't have many but I'm holding, actually would buy more if had some cash.
I read the release also and it does appear that the results from one phase appear to be screwed up. It indicates to me that a clinic in that phase made some gross errors in reporting the data. Investors are go "goosey" about the FDA and their current policies that any hic-up triggers them to bail, real or not real. When the findings get reported, I think you may see the stock shoot back up.